$DVA News

DaVita Inc. Schedules 2nd Quarter 2026 Investor Conference Call

DaVita HealthCare (DVA) Advances While Market Declines: Some Information for Investors

DaVita: Why We Exited Our Position In Q2

DaVita HealthCare (DVA) Rises As Market Takes a Dip: Key Facts

DaVita: I Believe This Is Overvalued

What You Need To Know Ahead of DaVita’s Earnings Release

Truist Securities Maintains Hold on DaVita, Raises Price Target to $250

DaVita HealthCare (DVA) Laps the Stock Market: Here's Why

UBS Maintains Buy on DaVita, Raises Price Target to $270

Barclays Maintains Equal-Weight on DaVita, Raises Price Target to $218

DaVita HealthCare (DVA) Suffers a Larger Drop Than the General Market: Key Insights

DaVita (DVA) Stock Could Be 19% Overvalued Despite Strong Q1 Results

Is DaVita Inc. (DVA) A Good Stock To Buy Now?

DaVita (DVA) Expands Integrated Kidney Care With AI Tools For Dialysis Care

Should Value Investors Buy DaVita (DVA) Stock?

Warren Buffett’s Berkshire Hathaway Has Held DaVita Inc. (DVA) Since 2011

DaVita Stock Benefits From Strengthening Kidney Care Delivery

Why the Market Dipped But DaVita HealthCare (DVA) Gained Today

DaVita HealthCare (DVA) Ascends While Market Falls: Some Facts to Note

Stronger Q1 Results And Kidney Care Expansion Might Change The Case For Investing In DaVita (DVA)